English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Business Development
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR+
  • Contact
  • Careers
  • English
  • Français

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • 2024 Annual Meeting
    • 2023 Annual Meeting
    • 2022 Annual Meeting
    • 2021 Annual Meeting
    • 2020 Annual Meeting
    • 2021 Special Meeting
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Presentation
  • Financial Results
  • Stock Data
    • TSX: MDP
    • OTCQX: MEDXF
    • Analyst Coverage
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEDAR+
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • 2024 Annual Meeting
  • 2023 Annual Meeting
  • 2022 Annual Meeting
  • 2021 Annual Meeting
  • 2020 Annual Meeting
  • 2021 Special Meeting
  • All Years
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • All Releases
  • Financial Releases
Sep 21, 2021 6:09pm EDT

Medexus Announces Expanded Availability of Trecondyv® (treosulfan) in Canada

Sep 16, 2021 4:30pm EDT

Medexus Holds Annual and Special Meeting of Shareholders and Announces Election of Board of Directors

Sep 02, 2021 8:30am EDT

Medexus Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 16, 2021 5:30pm EDT

Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022

Aug 12, 2021 7:30am EDT

Medexus Completes Enrollment in Phase 4 Clinical Trial of IXINITY® Targeting Label Expansion for Pediatric Hemophilia B Patients

Aug 10, 2021 1:00pm EDT

Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021

Aug 10, 2021 8:30am EDT

Medexus Schedules First Quarter Fiscal 2022 Conference Call

Aug 09, 2021 4:15pm EDT

Medexus to Present at Canaccord Genuity’s 41st Annual Growth Conference

Aug 04, 2021 10:58am EDT

Medexus Schedules Webinar to Discuss FDA Complete Response Letter for Treosulfan

Aug 03, 2021 7:45am EDT

Complete Response Letter Received from FDA for Treosulfan

RSS
  • Previous
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...19
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2025 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.